Clinical Trial

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-01-04; most recent amendment 2025-09-22.
Status change: Not Yet Recruiting → Recruiting 2025-09-22
Trial Details
NCT Number NCT05203328
Lead Sponsor The Cooper Health System
Conditions Lung Cancer
Enrollment 198 participants
Start Date 2022-02-01
Primary Completion 2026-03 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-25